iCubate

Collaborators said that the test is accurate and reliable for the rapid detection of the most common gram-positive bacteria responsible for bloodstream infections.

The company plans to launch a test for gram-negative bacteria next, and will work with developers and freelancers to develop additional assay content

Based on iCubate's Amplicon-Rescued Multiplex PCR technology, the iC-GPC assay is the first of the company's portfolio's to earn CE mark.

The iC-System is based on on iCubate's amplicon-rescued multiplex PCR technology, which detects multiple pathogens simultaneously.

Enrichment prior to amplification better enables studies of non-coding regions and epigenetic analyses, according to Ubiquity's founder.

Diatherix Laboratories, an independent CLIA-certified clinical laboratory providing multiplex molecular diagnostic services, said this week that it recently acquired from Qiagen the patent to target-enriched multiplexing, or TEM, PCR — a patent that Diatherix previously licensed

Samsung Electronics has been awarded US Patent No. 8,386,191, "Method for quantifying initial concentration of nucleic acid from real-time nucleic acid amplification data."
Kak Namkoong, Jin-tae Kim, Young-sun Lee, and Young-a Kim are named as inventors.

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.